Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sdwy2008
    Member
    • May 2010
    • 10

    How much does the uniquely mapping matter?

    Hi All,

    I have some RNA-seq data from Illumina (75 bp long). I found the percentage for uniquely mapping is really low (<=5%). What could be the reason:
    1. sample preparation?
    2. sequencing?
    3. mapping software?
    ....

    In addition, how much does the low uniquely mapping percentage matter? Would these data be usable?

    Thanks


  • severin
    Genome Informatics Facility
    • Sep 2009
    • 105

    #2
    RE: How much does the uniquely mapping matter

    sdwy2008,

    That really depends on the organism you are working on and if that organism is expected to have most of the genes duplicated. For instance, if an organism recently went through a whole genome duplication event then I might not expect to find many uniquely mappable reads. I work on soybean which has several whole genome duplication events, the most recent being about 13 million years ago and most of our reads are a mixture of uniquely mappable and highly repetitive (5% would be very low in this system from what I have seen). I have several data sets of Illumina 36-bp reads obtained from RNA.

    As for usability, it depends on what you want to determine using the data and as I mentioned above what kind of system you are working on. If you are looking to do an RNA-Seq analysis and have a good genome annotation try aligning to just the gene models rather than the entire genome. If you don't have good annotation consider aligning Solexa data to a 454 data run on RNA.

    It is challenging to answer your question without more information. I am leaving town tomorrow for Italy and will have unknown access to the internet. Best of luck

    Andrew

    Comment

    • jwfoley
      Senior Member
      • Jun 2009
      • 183

      #3
      Originally posted by sdwy2008 View Post
      Hi All,

      Would these data be usable?
      No. Even with a mammalian genome, you should be getting something like 50% uniquely mapping. 5% is so low that you don't just have less data, you almost certainly have bad data. Sorry.

      Unless you made some trivial error with the software, something is wrong with your sample.

      Comment

      • deks84
        Junior Member
        • Jun 2009
        • 5

        #4
        Hi all,

        I also have the same problem like sdwy2008. But my sequence is 36bp long. My case is supposedly mapping to human mRNA. I'm using Bowtie and I downloaded a few refseq related to human such as human.rna.fna, refseqgene.genomic.fna, complete1.rna.fna, bowtie pre-built indexes of human. I've tried map my raw sequence to all those references but I got mappable gene with 25-30% only.

        Actually, I want to know is it because of the references I chose is wrong? I mean, I tried to look for refseq human_mRNA release 28 but I couldn't find it. Can anyone help me where I can get this reference please?

        Comment

        • Simon Anders
          Senior Member
          • Feb 2010
          • 995

          #5
          Unless you know what you are doing it is probably better to use the standard approach of mapping even mRNA-Seq data to the genome, not to the transcriptome.

          This might even help you find the root of your problem: After all, if you map against an mRNA-only reference, you won't notice if most of your reads map on rRNA which would point to a problem with the rRNA-depletion step of your sample preparation.

          Also check your sample for low base-call quality or strange base compositions (e.g., using htseq-qa).

          Simon

          Comment

          • sdwy2008
            Member
            • May 2010
            • 10

            #6
            Originally posted by Simon Anders View Post
            Unless you know what you are doing it is probably better to use the standard approach of mapping even mRNA-Seq data to the genome, not to the transcriptome.

            This might even help you find the root of your problem: After all, if you map against an mRNA-only reference, you won't notice if most of your reads map on rRNA which would point to a problem with the rRNA-depletion step of your sample preparation.

            Also check your sample for low base-call quality or strange base compositions (e.g., using htseq-qa).

            Simon

            Sorry, I did not include more information about my experiment and analysis. The microorganism I am working on is some bacterium. I did have a (16s and 23s) rRNA-depletion step before the sequencing, but there were still some rRNA left in the treated samples, I think.

            I used Maq %map and %pileup to map my reads to the reference genome. With the default setting in %Maq map, I can map about 90% reads to the reference genome. However, in %Maq pileup, when I set the "-q INT Minimum mapping quality allowed for a read to be used" to 30, I had only <= 5% reads mapped UNIQUELY.

            So, by set q to 30, I thought the left reads are the UNIQUE mapped ones. However, I just took the q value from some similar published paper (http://www.plosgenetics.org/article/...l.pgen.1000569). I do not really know whether the setting is right??

            Could somebody who knows more about Maq give me some suggestion?

            Please also see my post at following link:

            Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


            Thanks!
            Last edited by sdwy2008; 06-07-2010, 12:16 PM.

            Comment

            • deks84
              Junior Member
              • Jun 2009
              • 5

              #7
              Originally posted by Simon Anders View Post
              Unless you know what you are doing it is probably better to use the standard approach of mapping even mRNA-Seq data to the genome, not to the transcriptome.

              This might even help you find the root of your problem: After all, if you map against an mRNA-only reference, you won't notice if most of your reads map on rRNA which would point to a problem with the rRNA-depletion step of your sample preparation.

              Also check your sample for low base-call quality or strange base compositions (e.g., using htseq-qa).

              Simon
              I forgot to mention that I'm doing differential expression gene analysis. I have 9 samples (tumor and control) of whole transcriptome sequencing. That's the reason I want to map to mRNA to look for the genes which expressed in this study. I also planned to map back to the genome. Will do after this.
              Actually I was confused between transcriptome assembly and transcriptome mapping. I mean in my case, should I do the assembly too? what will be recommended pipeline to do this analysis? I read in other thread of analysis pipeline http://seqanswers.com/forums/showthread.php?t=5248 and I have another person who did such analysis doing the same thing. Can somebody share their experience on this?

              Comment

              Latest Articles

              Collapse

              • mylaser
                Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by mylaser
                Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
                The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
                Whether you're exploring Kheloyaar for the first time or want to understand...
                Yesterday, 09:27 PM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                Yesterday, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 10:04 AM
              0 responses
              8 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              7 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-07-2026, 11:05 AM
              0 responses
              11 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-02-2026, 11:08 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Working...